 |
|
|
| |
EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS
|
| |
| |
Reported by Jules Levin
EASL April 23-26 2009-04-30
Copenhagen, Denmark
D.R. Nelson, R.H. Ghalib, M. Sulkowski, E. Schiff, V. Rustgi, P.J. Pockros,
C. Wang, G. Decosterd, P. Grosgurin , H. Porchet, R. Crabbe
|
| |
|
|
|
|
|
